These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 12488361

  • 1. Soluble vascular endothelial growth factor receptor 1 inhibits edema and epithelial proliferation induced by 17beta-estradiol in the mouse uterus.
    Hastings JM, Licence DR, Burton GJ, Charnock-Jones DS, Smith SK.
    Endocrinology; 2003 Jan; 144(1):326-34. PubMed ID: 12488361
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of vascular endothelial growth factor/vascular permeability factor action blocks estrogen-induced uterine edema and implantation in rodents.
    Rockwell LC, Pillai S, Olson CE, Koos RD.
    Biol Reprod; 2002 Dec; 67(6):1804-10. PubMed ID: 12444056
    [Abstract] [Full Text] [Related]

  • 3. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen.
    Hyder SM, Stancel GM, Chiappetta C, Murthy L, Boettger-Tong HL, Makela S.
    Cancer Res; 1996 Sep 01; 56(17):3954-60. PubMed ID: 8752163
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth.
    Cullinan-Bove K, Koos RD.
    Endocrinology; 1993 Aug 01; 133(2):829-37. PubMed ID: 8344219
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of systemic and local IGF-I in the effects of estrogen on growth and epithelial proliferation of mouse uterus.
    Sato T, Wang G, Hardy MP, Kurita T, Cunha GR, Cooke PS.
    Endocrinology; 2002 Jul 01; 143(7):2673-9. PubMed ID: 12072401
    [Abstract] [Full Text] [Related]

  • 8. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria.
    Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R.
    J Biol Chem; 2003 Apr 11; 278(15):12605-8. PubMed ID: 12538598
    [Abstract] [Full Text] [Related]

  • 9. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.
    Hervé MA, Meduri G, Petit FG, Domet TS, Lazennec G, Mourah S, Perrot-Applanat M.
    J Endocrinol; 2006 Jan 11; 188(1):91-9. PubMed ID: 16394178
    [Abstract] [Full Text] [Related]

  • 10. Expression of vascular endothelial growth/permeability factor by endometrial glandular epithelial and stromal cells in baboons during the menstrual cycle and after ovariectomy.
    Niklaus AL, Babischkin JS, Aberdeen GW, Pepe GJ, Albrecht ED.
    Endocrinology; 2002 Oct 11; 143(10):4007-17. PubMed ID: 12239112
    [Abstract] [Full Text] [Related]

  • 11. 17 Beta-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells.
    Suzuma I, Mandai M, Takagi H, Suzuma K, Otani A, Oh H, Kobayashi K, Honda Y.
    Invest Ophthalmol Vis Sci; 1999 Aug 11; 40(9):2122-9. PubMed ID: 10440269
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of angiogenesis inhibitors on oestrogen-mediated endometrial endothelial cell proliferation in the ovariectomized mouse.
    Heryanto B, Lipson KE, Rogers PA.
    Reproduction; 2003 Mar 11; 125(3):337-46. PubMed ID: 12611597
    [Abstract] [Full Text] [Related]

  • 14. Uterotrophic effects of tamoxifen, toremifene, and raloxifene do not predict endometrial cell proliferation in the ovariectomized CD1 mouse.
    Carthew P, Edwards RE, Nolan BM.
    Toxicol Appl Pharmacol; 1999 Jul 01; 158(1):24-32. PubMed ID: 10387929
    [Abstract] [Full Text] [Related]

  • 15. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.
    He Y, Smith SK, Day KA, Clark DE, Licence DR, Charnock-Jones DS.
    Mol Endocrinol; 1999 Apr 01; 13(4):537-45. PubMed ID: 10194760
    [Abstract] [Full Text] [Related]

  • 16. The mitogenic effect of 17beta-estradiol on in vitro endothelial cell proliferation and on in vivo reendothelialization are both dependent on vascular endothelial growth factor.
    Concina P, Sordello S, Barbacanne MA, Elhage R, Pieraggi MT, Fournial G, Plouet J, Bayard F, Arnal JF.
    J Vasc Res; 2000 Apr 01; 37(3):202-8. PubMed ID: 10859479
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M, Hoffmann S, Hassan I, Wunderlich A, Hofbauer LC, Zielke A.
    Exp Clin Endocrinol Diabetes; 2002 Nov 01; 110(8):386-92. PubMed ID: 12518248
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of the estradiol-mediated endometrial gland formation by the antigestagen onapristone in rabbits: relationship to uterine estrogen receptors.
    Chwalisz K, Hegele-Hartung C, Fritzemeier KH, Beier HM, Elger W.
    Endocrinology; 1991 Jul 01; 129(1):312-22. PubMed ID: 2055191
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.